| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Tandem Diabetes Care, Inc.'s insiders have reduced their positions by a net 1,700 shares worth roughly $33K. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 160.3K | $2.83M | - | |
| VP | 52.8K | $931.7K | - | |
| CFO | 52.0K | $918.5K | - | |
| VP | 40.3K | $711.6K | - | |
| VP | 32.1K | $567.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2020 | Brian B Hansen | EVP & Chief Commercial Officer | Sale+OE | 10,000 | $69.76 | $697,620.00 | -77.0% | |
| Dec 16, 2019 | Kim D Blickenstaff61 | Executive Chairman | Sell | 200,000 | $59.85 | $11,970,491.03 | -22.4% | |
| Nov 25, 2019 | John F Sheridan55 | President & CEO | Sale+OE | 462 | $70.00 | $32,340.00 | -15.6% | |
| Nov 25, 2019 | Leigh Vosseller76 | EVP & Chief Financial Officer | Sale+OE | 10,000 | $70.35 | $703,500.00 | -75.4% | |
| Nov 18, 2019 | Leigh Vosseller76 | EVP & Chief Financial Officer | Sale+OE | 10,000 | $65.41 | $654,128.00 | -75.4% | |
| Nov 4, 2019 | Brian B Hansen | EVP & Chief Commercial Officer | Sale+OE | 15,000 | $62.01 | $930,130.50 | -83.4% | |
| Sep 6, 2019 | John F Sheridan55 | President & CEO | Sale+OE | 9,538 | $70.03 | $667,946.14 | -79.2% | |
| Sep 3, 2019 | David B Berger79 | EVP, Chief Legal & Compliance | Sale+OE | 2,000 | $72.00 | $144,000.00 | -37.7% | |
| Aug 29, 2019 | Kim D Blickenstaff61 | Executive Chairman | Sell | 100,000 | $70.96 | $7,096,200.00 | -10.1% | |
| Aug 28, 2019 | Douglas A Roeder70 | Director | Sell | 308,297 | $70.32 | $21,680,376.26 | -97.0% |